1094100-62-5

Basic information

• Product Name: (E)-5-(4-(2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoyloxy)styryl)-1,3-phenylene diacetate
• Synonyms: (E)-5-(4-(2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoyloxy)styryl)-1,3-phenylene diacetate
• CAS NO: 1094100-62-5
• Molecular Weight: 613.063
• Mol File: 1094100-62-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (E)-5-(4-(2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoyloxy)styryl)-1,3-phenylene diacetate(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-5-(4-(2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoyloxy)styryl)-1,3-phenylene diacetate(1094100-62-5)
• EPA Substance Registry System: (E)-5-(4-(2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoyloxy)styryl)-1,3-phenylene diacetate(1094100-62-5)

Safety Data

• Hazardous Substances Data: 1094100-62-5(Hazardous Substances Data)

Upstream product

• 1094101-24-2 4-iodophenyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate 
• 155222-48-3 5-vinyl-1,3-phenylene diacetate 

Downstream Products

• 1094098-94-8 (E)-4-(3,5-dihydroxystyryl)phenyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate 

Relevant articles and documents

COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS

Disclosed herein are novel compositions and methods for treating or preventing a variety of disorders and conditions associated with lipid metabolism. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising one or more fibric acid or statin derivative compositions alone or in combination with one or more lipid altering agents and/or PDE inhibitors.